NF2 and schwannomatosis: In NF1, NF2, and schwannomatosis (SWN), emerging technical advances, particularly WB-MRI as well as DWI/ADC mapping, in conjunction with clinical and genetic data, can potentially provide insight into both disease severity as well as tumor behavior [55–57].